MBOT — Microbot Medical Balance Sheet
0.000.00%
- $16.76m
- $10.41m
Annual balance sheet for Microbot Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 31.3 | 24.6 | 15.5 | 8.21 | 6.38 |
Net Total Receivables | 0.101 | 0.07 | 0.174 | 0.103 | 0.061 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 35.9 | 25.3 | 15.9 | 8.81 | 7.92 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.19 | 1.03 | 0.888 | 0.723 | 0.406 |
Total Assets | 37.1 | 26.3 | 16.8 | 9.54 | 8.33 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.83 | 1.34 | 1.98 | 2.07 | 3.79 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.59 | 1.97 | 2.39 | 2.25 | 3.83 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 31.5 | 24.3 | 14.4 | 7.29 | 4.5 |
Total Liabilities & Shareholders' Equity | 37.1 | 26.3 | 16.8 | 9.54 | 8.33 |
Total Common Shares Outstanding |